Amedisys to Combine With Option Care Health in $9.7 Billion Deal

Paul, Weiss is advising Amedisys, Inc. in its combination with Option Care Health, Inc. in an all-stock transaction that values the combined company at $9.7 billion. The combination of Amedisys' home health, hospice, palliative and high-acuity care services with Option Care Health’s complementary home and alternate site infusion services will create a scaled, national platform for home and alternate site care.

Upon closing, stockholders of Option Care Health will own approximately 64.5% of the combined company, and Amedisys stockholders will own approximately 35.5%. The transaction is expected to close in the second half of 2023, subject to customary closing conditions and regulatory approvals.

The Paul, Weiss team is led by M&A partners Kyle Seifried and Krishna Veeraraghavan, and includes, among others, corporate partner Christopher Cummings and counsel Steve Centa and Frances Mi; executive compensation partners Jean McLoughlin and Rebecca Coccaro, and counsel Sasha Belinkie; litigation partners Geoffrey Chepiga, and Joshua Soven, and counsel Steven Herzog and Jared Nagley; tax partner Brian Krause; intellectual property partner Jonathan Ashtor and counsel Marisa Geiger; real estate partner Peter Fisch; antitrust counsel Marta Kelly; and environmental counsel William O'Brien.